Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells
Abstract
Hesperidin, a flavonoid, shows strong cytotoxic effect in several cancer cell lines. The aim of this research was to investigate cytotoxic activities of hesperidin alone and in combination with doxorubicin. Cell viability assay of hesperidin, doxorubicin, and combination treatments were carried out by using MTT assay. Apoptosis assay was done using double staining method using Ethidium Bromide-Acridine Orange. Hesperidin did not show cytotoxic effect but doxorubicin showed cytotoxic effect with IC50467 nM. Hesperidin (5, 50 and 100 µM) increased cytotoxic effect of doxorubicin compared with doxorubicin alone. The strongest cytotoxic activity was showed by the combination of 200 nM doxorubicin and 100 µM hesperidin. Combination treatment of doxorubicin 200 nM and hesperidin 100 µM induced apoptosis in MCF-7 cells. Hesperidin is potentially to be developed as co-chemotherapeutic agent for breast cancer, while molecular mechanism need to be explored.
Key words: Hesperidin, doxorubicin, synergism, MCF-7, apoptosis
Full Text:
PDF 8-17References
Adina, A. B., Handoko, F. F., Setyarini, I. I., Septisetyani, E. P., Riyanto, S., and Meiyanto, E., 2008. Ekstrak Etanolik Kulit Jeruk Nipis (Citrus aurantifolia (Cristm.) Swingle) Meningkatkan Sensitivitas Sel MCF-7 terhadap Doxorubicin, Proceding, Kongres Ilmiah ISFI ke-16, Yogyakarta, ISBN:978-979-95107-6-2, 55-62.
Anonim, 2009, Yayasan Kesehatan Payudara Jakarta RS. Kanker Dharmais, http://www.pitapink.com/id/salam.htmLdiakses pada 20 Oktober.
Arafa, H., Aly, H., Abd-Ellah, M., and El-Refaey, H., 2009. Hesperidin attenuates benzo[{alpha}] pyrene-induced testicular toxicity in rats via regulation of oxidant/antioxidant balance, Toxicol Ind Health., 6, 417-427.
Bourguignon, L. Y., Xia, W., and Wong, G., 2009. Hyaluronan-Mediated CD44 Interaction with p300 and SIRT1 Regulates Beta-catenin Signaling and NFkappaB-Specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells. J. Biol Chem, 284,2657-2671.
Chiba, H., Uehara, M., Wu, J., Wang, X., Masuyama, R., Suzuki, K., Kanazawa, K., and Ishimi, Y., 2003. Hesperidin, a Citrus Flavonoid, Inhibits Bone Loss and Decreases Serum and Hepatic Lipids in Ovariectomized Mice, Journal of Nutrition,133, 1892-1897.
Choi, S., Ko, H., Ko, S., Hwang, J., Park, J., Kang, S., Han, S., Yun, S., and Kim, S., 2007. Correlation between Flavonoid Content and the NO Production Inhibitory Activity of Peel Extracts from Various Citrus Fruits, Biol. Pharm. Bull., 30, 4, 772-778.
Chung, S. Y., Sung, M. K., Kim, N. H., Jang, J. O., Go, E. J., and Lee, H. J., 2005. Inhibition of glycoprotein By Natural Products in Human Breast Cancer Cells, Arch Pharm Res., 28, 823-828.
Davis, J. M., Navolanic, P. M., Weinstein-Oppenheimer, C. R., Steelman, L. S., Wei H., Konopleva, M., Blagosklonny, M. V. and McCubrey, J. A., 2003. Raf-1 and Bcl-2 Induce Distinct and Common Pathways That Contribute to Breast Cancer Drug Resistance. Clin. Canc. Res.9, 1161-1170.
El-Readi, M. Z., Hamdan, D., Farrag, N., El-Shazly, A., and Wink, M., 2009. Inhibition of Pglycoprotein Activity by Limonin and Other Secondary Metabolites from Citrus Species in Human Colon and Leukaemia Cell Lines, Eur. J. Pharmacol., doi:10.1016/j.ejphar.2009.09.040.
Fimognari, C., Nusse, M. N., Lenzi, M., Sciuscio, D., Cantelli-Forti, G., Hrelia, P., 2006. Sulforaphane Increases the Efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations, Mutation Research, 601, 92–101.
Gewirtz, D. A., 1999A. critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem. Pharmacol.,57, 727-741.
Gu, Q., Wang, D., Wang, X., Peng, R., Liu, J., Jiang, T., Wang, Z., Wang, S., and Deng, H., 2004. Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of BAD, Radiat Res., 161, 692-702.
Hastuti, N, Pratiwi, D., Armandari I., Nur W. Niken, Ikawati, M., Riyanto, S., and Meiyanto, E., 2008. Ekstrak Etanolik Kulit Jeruk Nipis (Citrus aurantiifollia (Cristm.) Swingle) Menginduksi Apopotosis Pada sel Payudara Tikus Galur Sprague Dawley Terinduksi 7,12-Dimetilbenz[a]antrasena, Proceeding Kongres Ilmiah XVI Ikatan Sarjana Farmasi Indonesia, ISBN: 978-979-95108-6-0, ISFI, 94 – 99.
Ikegawa, T., Ohtani, H., Koyabu, N., Juichi, M., Iwase, Y., Ito, C., Furukawa, H., Naito, M., Tsuruo, T., and Sawada, Y., 2002. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin resistant human myelogenous leukemia (K562/ADM) cell., Cancer Lett., 177, 89-93.
Lee, C. J., Wilson, L., Jordan, M. A., Nguyen, V., Tang, J., and Smiyun, G., 2009. Hesperidin Suppressed Proliferations of Both Human Breast Cancer and Androgen-dependent Prostate Cancer Cells, Phytother Res., In Press.
Li, S., Zhou, Y., Wang, R., Zhang, H., Dong Y., and Ip, C., 2007. Selenium Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis Through Modulation of PhosphoAkt and Its Downstream Substrates, Mol Cancer Ther., 6:1031-1038.
McGahon, A. J., Martin, S. J., Bissonnette, R. P., Mahboubi, M., Shi, Y., Mogil, R. J., Nishioka, W. K., and Green, D. R., 1995. The End of the (Cell) Line: Methods for the Study of Apoptosis in Vitro, in: Schwartz, L. M., Osborn, B. A., Cell Death, Academic Press, San Diego.
Mealey, K. L., Barhoumi, R., Burghardt, R. C., Safe, S. and Kochevar, D. T., 2002. Doxycycline Induces Expression of P Glycoprotein in MCF-7 Breast Carcinoma Cells. Antimicrobial Agents and Chemotherapy, 46, 755-761.
Meiyanto, E., Handayani, S., Septisetyani, E. P., and Susidarti, R. A., 2009. Synergistic Effect of Areca catechu L. Ethanolic Extract and Its Chloroform Fraction with Doxorubicin on MCF-7, Jurnal Ilmu Kefarmasian Indonesia, 7, 13-18.
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. and Gianni, L., 2004. Anthracyclins: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev56, 185-228.
Nabekura, T., Yamaki, T., and Kitagawa, S., 2008. Effects of Chemopreventive Citrus Phytochemicals on Human P-glycoprotein and Multidrug Resistance Protein 1, E. J.of Pharmacology, 600, 45–49.
Olivier, S., Robe, P., and Bours, V., 2006. Can NF-kB be a Target for Novel and Efficient AntiCancer Agents?, B i ochemical Pharmacology, 72, 1054-1068.
Park, H., Kim, M. J., Ha, E., and Chung, J. H., 2008. Apoptotic Effect of Hesperidin Through Caspase3 Activation in Human Colon Cancer Cells, SNU-C4, Phytomedecine, 15, 1-2, 147-151.
Powell, S. R., and McCay, P. B., 1995. Inhibition of Doxorubicin-Induced Membrane Damage by Thiol Compounds: Toxicologic Implications of a Glutathione-Dependent Microsomal Factor, Free Radical Biology & Medicine, 18, 159-168.
Shehata, M. F., 2005. Rel/Nuclear Factor-kappa B Apoptosis Pathways in Human Cervical Cancer Cells. Review., Cancer Cell International, 5, 10-23.
Simstein, R., Burow, M., Parker A., Weldon, C. and Beckman, B., 2003. Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System. Exp Biol Med. 228, 995–1003.
Tokarska-Schlattner, M., Zaugg, M., Zuppinger, C., Wallimann, T., and Schlattner, U., 2006. New Insights into Doxorubicin-induced Cardiotoxicity: The Critical Role of Cellular Energetics, Journal of Molecular and Cellular Cardiology, 41, 389–405.
Yeh, C. C., Kao, S. J., Lin, C. C., Wang, S. D., Liu, C. J., and Kao, S. T., 2007, The Immunomodulation of Endotoxin-Induced Acute Lung Injury by Hesperidin in vivo and in vitro, Life Sciences, 80, 1821–1831.
Zampieri, L., Bianchi, P., Ruff, P., and Arbuthnot, P., 2002. Differential Modulation by Estradiol of P-glycoprotein Drug Resistance Protein Expression in Cultured MCF7 and T47D Breast Cancer Cells, Anticancer Res., 22, 2253-2259.
Zhang, C., Lu, Y., Tao, L., Su, X., and Wei, D., 2007. Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts, J Enzyme Inhib Med Chem. 22, 1, 91-98.
DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp8-17
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by: